【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 8
2 Pharmaceuticals & Healthcare, Global, Deal Summary 12
2.1 Pharmaceuticals & Healthcare, Global, Deal Analysis, October 2013 12
2.2 Pharmaceuticals & Healthcare, Global, Major Deals, October 2013 14
2.2.1 McKesson to Acquire Celesio for US$8.3 Billion 14
2.2.2 Bristol-Myers Squibb Completes Public Offering of Notes for US$1.5 Billion 16
2.2.3 Ventas Acquires Portfolio of Independent Living Communities from Holiday Retirement for US$790 Million 16
2.2.4 BioMarin Pharma Completes Public Offering of Notes for US$750 Million 16
2.2.5 Astellas Pharma Enters Into R&D Agreement with Mitokyne for Drug Discovery 17
2.3 Pharmaceuticals & Healthcare, Global, by Type, Number of Deals, October 2013 18
2.4 Pharmaceuticals & Healthcare, Global, by Type, Deal Values, October 2013 19
3 Pharmaceuticals and Healthcare, Global, Deals, Summary, by Type 20
3.1 Pharmaceuticals & Healthcare, Global, M&A, October 2013 20
3.1.1 Top M&A Deals in October 2013 21
3.1.2 Pharmaceuticals & Healthcare, Global, M&A Deals by Therapy Area, May 2013 – October 2013 22
3.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, October 2013 23
3.2.1 Top Equity Offering Deals in October 2013 24
3.2.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals by Therapy Area, May 2013 – October 2013 25
3.3 Pharmaceuticals & Healthcare, Global, Private Equity and Venture Capital Deals, October 2013 27
3.3.1 Top PE/VC Deals in October 2013 28
3.3.2 Pharmaceuticals & Healthcare, Global, PE/VC by Therapy Area, October 2013 29
3.3.3 Pharmaceuticals & Healthcare, Global, Venture Capital Deals by Stage of Financing, October 2013 31
3.3.4 Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, May 2013-October 2013 33
3.3.5 Pharmaceuticals & Healthcare, Global, Top VC Backed Companies, May 2013-October 2013 34
4 Pharmaceuticals & Healthcare, Global, Partnership Deals, October 2013 35
4.1 Pharmaceuticals & Healthcare, Global, Partnership Deals, October 2013 35
4.2 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, May 2013 – October 2013 37
4.3 Pharmaceuticals & Healthcare, Global, Partnership Deals by Upfront and Milestone Payments and Deal Values (US$ m), October 2013 39
4.3.1 Pharmaceuticals & Healthcare, Global, Top Partnership Deals by Payment Mode, October 2013 41
4.4 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, by Upfront and Milestone Payments and Deal Values (US$ m), May 2013 – October 2013 42
4.5 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Number Of Deals, May 2013 – October 2013 44
4.6 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Deal Values (US$ m), May 2013 – October 2013 45
4.7 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), May 2013 – October 2013 47
5 Pharmaceuticals & Healthcare, Global, Licensing Agreements, October 2013 49
5.1 Pharmaceuticals & Healthcare, Global, Licensing Agreements, October 2013 49
5.2 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Upfront and Milestone Payments and Deal Values (US$ m), October 2013 51
5.2.1 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements by Deal Value, October 2013 53
5.2.2 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Total Upfront Payments, October 2013 53
5.2.3 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements by Total Milestone Payment, October 2013 54
5.3 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Total Deal Values (US$ m), May 2013 – October 2013 55
5.4 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Upfront Payments and Milestone Payments (US$ m), May 2013 – October 2013 57
5.5 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Total Deal Values (US$ m), May 2013 – October 2013 59
5.6 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Upfront Payments and Milestone Payments (US$ m), May 2013 – October 2013 61
6 Pharmaceuticals & Healthcare, Global, Deal Summary by Therapy Area 63
6.1 Pharmaceuticals & Healthcare, Global, Oncology Deals, October 2013 63
6.1.1 Oncology – Deals of the Month 65
6.2 Pharmaceuticals & Healthcare, Global, Central Nervous System Deals, October 2013 67
6.2.1 Central Nervous System – Deals of the Month 69
6.3 Pharmaceuticals & Healthcare, Global, Immunology Deals, October 2013 70
6.3.1 Immunology – Dealsof the Month 72
6.4 Pharmaceuticals & Healthcare, Global, Infectious Disease Deals, October 2013 73
6.4.1 Infectious Diseases – Deals of the Month 75
6.5 Pharmaceuticals & Healthcare, Global, Metabolic Disorder Deals, October 2013 76
6.5.1 Metabolic Disorders – Deal of the Month 78
6.6 Pharmaceuticals & Healthcare, Global, Cardiovascular Deals, October 2013 81
6.6.1 Cardiovascular – Deal of the Month 82
6.7 Pharmaceuticals & Healthcare, Global, Hematological Disorders, Deals, October 2013 84
6.7.1 Hematological Disorders – Deal of the Month 85
7 Deal Summary by Geography 87
7.1 Pharmaceuticals & Healthcare, North America Deals, October 2013 87
7.1.1 North America – Deals of the Month 89
7.2 Pharmaceuticals & Healthcare, Europe, Deals, October 2013 91
7.2.1 Europe – Deals of the Month 92
7.3 Pharmaceuticals & Healthcare, Asia-Pacific, Regional Deals, October 2013 94
7.3.1 Asia-Pacific – Deals of the Month 96
7.4 Pharmaceuticals & Healthcare, Rest of the World, Deals, October 2013 97
7.4.1 Rest of the World – Deals of the Month 99
8 Pharmaceuticals & Healthcare, Global, Top Financial Advisors 100
8.1 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, M&A, May 2013 – October 2013 100
8.2 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, May 2013 – October 2013 102
9 Further Information 104
9.1 Methodology 104
9.2 About GlobalData 105
9.3 Disclosure information 106
9.4 Disclaimer 106
【レポート販売概要】
■ タイトル：Pharmaceuticals Monthly Deals Analysis: October 2013 – Partnerships, Licensing, Investments and M&A Trends■ 英文：Pharmaceuticals Monthly Deals Analysis: October 2013 - Partnerships, Licensing, Investments and M&A Trends
■ 発行日：2013年11月30日
■ 調査会社：GlobalData
■ 商品コード：GDATA403162982
■ 調査対象地域：グローバル
- コネクテッド・ヘルスの世界市場：健康モニタリング機器、健康診断・治療機器About Connected Health Connected health focuses on optimizing available healthcare resources to facilitate personalized, flexible options for client-physician interaction and self-care. It uses technology to deliver healthcare services remotely. Connected health programs leverage advanced technologies like connected devices using established cellular networks to offer solutions such as telehealth, …
- トルエンの世界市場予測Toluene 2014 World Market Outlook and Forecast is an absolutely essential resource for anyone looking for detailed information on the mentioned market. Using a wide range of primary and secondary sources, we combined, analyzed and presented all available data about toluene market in the all-in-one report issued in a logical and easily accessible format. In addition to the analytical part, the repo …
- 3Dイメージングの世界市場：技術（アナグリフィ、立体視、ホログラフィー、立体ディスプレイ）、ソリューション（3Dモデリング、3Dスキャニング）、装置（3Dディスプレイ、3Dセンサ）There has been a substantial rise in the usage of three dimensional technologies in the past five years. This expansion of 3D technologies has increased due to the rise in the demand for extensive technologies among customers. With the rise in the usage of these 3D imaging technologies, there has been significant increase in the adoption of 3D imaging solutions among various enterprises. The incre …
- 農業用フェロモンの世界市場予測（～2022年）“The pheromones market in agriculture is projected to grow at a CAGR of 16.26%.”The agricultural pheromones market is estimated to be USD 1.99 million in 2017, growing at a CAGR of 16.26% from 2017 to reach USD 4.23 billion by 2022. Even though simpler production processes can bring down the manufacturing costs, the pheromones market has still been largely evolving with many manufacturers involved …
- 医療レポート：Diabetic Retinopathy-疫学予測（～2022）EpiCast Report: Diabetic Retinopathy - Epidemiology Forecast to 2022 Summary Diabetic retinopathy is the principal cause of vision impairment in working-age adults throughout the world. A common microvascular complication of diabetes, diabetic retinopathy affects a third of diagnosed diabetics (Cheung et al., 2010). Clinically defined as an eye disease damaging the small blood vessels in the retin …
- Eladur（神経因性疼痛）：医薬品市場予測及び分析（～2022）Eladur (Neuropathic Pain) - Forecast and Market Analysis to 2022 Summary Neuropathic pain (NP) is defined as a disorder of the sensorimotor system and is distinctly different from nociceptive pain, which is a consequence of trauma, injury, or inflammation. The main difference between neuropathic and nociceptive pain is the absence of a continuous nociceptive input in neuropathic pain. Although the …
- スポーツ栄養及びフィットネス用サプリメントの世界市場：タンパク質バー、エネルギージェル、エネルギーバー、タンパク質粉末、スポーツドリンク、エネルギードリンクVisiongain’s brand new 127 page report reveals that the world sports nutrition & fitness supplements market will achieve revenues of $64.17bn in 2015. Are you involved in the Sports Nutrition & Fitness Supplements market or intend to be? If so, then you must read this report It’s vital that you keep your knowledge up to date. You need this report. Market scope: The sports nutrition & fitness suppl …
- 過眠症（Hypersomnia）：グローバル臨床試験動向（2014年上半期）Hypersomnia Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Hypersomnia Global Clinical Trials Review, H1, 2014" provides data on the Hypersomnia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hypersomnia. It includes an overview of the trial numbers and their recruitment status as per the site of …
- UAVドローンの世界市場予測（～2022年）The global UAV drones market size is expected to increase to USD 21.23 Billion by 2022, at a CAGR of 19.99% between 2016 and 2022. The drivers for this market are rapid technological advancements in drones, growing demand for drone-generated data in commercial applications, increasing demand for drones in commercial applications, and rapid technological advancements in drones. Among all the major …
- ロボット掃除機の世界市場予測・分析2020-2024Global Robotic Vacuum Cleaner Market: About this market Technavio’s robotic vacuum cleaner market analysis considers sales from both the residential sector and commercial end-users. Our study also finds the sales of robotic vacuum cleaner in APAC, Europe, MEA, North America, and South America. In 2019, the residential sector segment had a significant market share, and this trend is expected to con …
- グローバルベーカリー製品市場（～2019）The industry report Global Bakery Product Market to 2019 - Market Size, Development, and Forecasts offers the most up-to-date market data on the actual market situation, and future outlook for bakery products in the world. The research includes historic market data from 2008 to 2014 and forecasts until 2019 which makes the report an invaluable resource for industry executives, marketing, sales and …
- LTE/LTE以降におけるキャリアWiFiおよびスモールセル：市場機会及び予測Mobile network operator "Heterogeneous Networks" (HetNet) are based on a combination of small cells, macro cells and carrier WiFi. HetNets are expected to play a pivotal role in addressing network capacity needs, bring about improvements in carrier operations, and create opportunities for new revenue streams. This research provides an in-depth assessment of the carrier WiFi and small cells market, …
- 下痢(Diarrhea)：世界の治験レビュー（2015年上半期版）Diarrhea Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Diarrhea Global Clinical Trials Review, H1, 2015" provides an overview of Diarrhea clinical trials scenario. This report provides top line data relating to the clinical trials on Diarrhea. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe …
- 世界の染料及び有機顔料市場2015The Global Dyes & Organic Pigments Industry Report 2015 is a professional and in-depth study on the current state of the Dyes & Organic Pigments industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Dyes & Organic Pigments market analysis is provided for the international markets including development tr …
- LTE及びLTE-Advanced端末市場（LTE and LTE-Advanced Devices: Market Share, Key Trends, Vendor Strategies, Shipments, Revenue & Forecasts by Region and Country Q1'2012）2012 is a turning point for the mobile devices market as most device vendors go full swing into LTE. Having already witnessed several device launches, and shipments of over 8 Million units in 2011, the LTE devices ecosystem is set to grow at a CAGR of over 104 % over the next five years. In 2016, there will be nearly 300 Million LTE device shipments all over the globe, with revenues of over 82 Bil …
